ASCO 2024: Using Molecular Testing to Guide Perioperative Systemic Therapy for Urothelial Cancer
ASCO 2024 molecular testing to guide perioperative systemic therapy for urothelial cancer, ctDNA testing, adjuvant immune checkpoint blockade, TOMBOLA trial.